South Korea · Delayed Price · Currency is KRW Union Korea Pharm Statistics
Total Valuation
KOSDAQ:080720 has a market cap or net worth of KRW 19.70 billion. The enterprise value is 51.10 billion.
| Market Cap | 19.70B |
| Enterprise Value | 51.10B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:080720 has 2.41 million shares outstanding. The number of shares has increased by 121.77% in one year.
| Current Share Class | 2.41M |
| Shares Outstanding | 2.41M |
| Shares Change (YoY) | +121.77% |
| Shares Change (QoQ) | +290.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.26 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.17 |
| Interest Coverage | -14.16 |
Financial Efficiency
Return on equity (ROE) is -137.86% and return on invested capital (ROIC) is -558.73%.
| Return on Equity (ROE) | -137.86% |
| Return on Assets (ROA) | -18.59% |
| Return on Invested Capital (ROIC) | -558.73% |
| Return on Capital Employed (ROCE) | -60.28% |
| Weighted Average Cost of Capital (WACC) | 8.53% |
| Revenue Per Employee | 153.34M |
| Profits Per Employee | -146.40M |
| Employee Count | 166 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.81 |
Taxes
In the past 12 months, KOSDAQ:080720 has paid 3.01 billion in taxes.
| Income Tax | 3.01B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.76% in the last 52 weeks. The beta is 0.08, so KOSDAQ:080720's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -43.76% |
| 50-Day Moving Average | 13,133.70 |
| 200-Day Moving Average | 15,384.90 |
| Relative Strength Index (RSI) | 32.14 |
| Average Volume (20 Days) | 142,203 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:080720 had revenue of KRW 25.45 billion and -24.30 billion in losses. Loss per share was -4,545.51.
| Revenue | 25.45B |
| Gross Profit | 2.49B |
| Operating Income | -21.47B |
| Pretax Income | -21.29B |
| Net Income | -24.30B |
| EBITDA | -19.99B |
| EBIT | -21.47B |
| Loss Per Share | -4,545.51 |
Balance Sheet
The company has 37.43 billion in cash and 5.21 billion in debt, with a net cash position of 32.22 billion or 13,370.92 per share.
| Cash & Cash Equivalents | 37.43B |
| Total Debt | 5.21B |
| Net Cash | 32.22B |
| Net Cash Per Share | 13,370.92 |
| Equity (Book Value) | 33.68B |
| Book Value Per Share | 2,553.83 |
| Working Capital | 11.09B |
Cash Flow
In the last 12 months, operating cash flow was -1.56 billion and capital expenditures -78.57 million, giving a free cash flow of -1.64 billion.
| Operating Cash Flow | -1.56B |
| Capital Expenditures | -78.57M |
| Depreciation & Amortization | 1.49B |
| Net Borrowing | 4.34B |
| Free Cash Flow | -1.64B |
| FCF Per Share | -681.72 |
Margins
Gross margin is 9.77%, with operating and profit margins of -84.35% and -95.48%.
| Gross Margin | 9.77% |
| Operating Margin | -84.35% |
| Pretax Margin | -83.64% |
| Profit Margin | -95.48% |
| EBITDA Margin | -78.52% |
| EBIT Margin | -84.35% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:080720 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -121.77% |
| Shareholder Yield | -121.77% |
| Earnings Yield | -123.36% |
| FCF Yield | -8.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |